Disc Medicine, Inc. (IRON) — 10-Q Filings

10-Q Filings (6)

• Disc Medicine's Losses Double Amid Soaring R&D Costs — Nov 6, 2025 Risk: high
  Disc Medicine, Inc. (IRON) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $151.653 million, a substantial ri
• Disc Medicine's Q2 Loss Widens to $49.8M Amid R&D Ramp-Up — Aug 7, 2025 Risk: high
  Disc Medicine, Inc. reported a net loss of $49.8 million for the three months ended June 30, 2025, an increase from a net loss of $40.2 million for the same per
• Disc Medicine Files Q1 2025 10-Q, Details Mabwell & Roche Deals — May 7, 2025 Risk: medium
  Disc Medicine, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business activities, including de
• Disc Medicine Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Disc Medicine, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business operati
• Disc Medicine Files Q2 2024 10-Q, Cites R&D and License Deal — Aug 8, 2024 Risk: medium
  Disc Medicine, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported research and development expenses for the first six months of 2024
• Disc Medicine, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  Disc Medicine, Inc. (IRON) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Disc Medicine, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX